Cargando…
Primary malignant melanoma of the male urethra: a case report
We present a rare case of a 69-year-old male patient with serendipitous urethral melanoma. He complained of dysuria and recurrent urinary retention and was initially diagnosed with benign prostatic hyperplasia. Accidentally, a dark-brown pigmented macula was found in the distal urethra at the end of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798279/ https://www.ncbi.nlm.nih.gov/pubmed/35116351 http://dx.doi.org/10.21037/tcr-21-1150 |
_version_ | 1784641763579789312 |
---|---|
author | Duan, Liqun Liu, Sanhe Li, Yongzhi |
author_facet | Duan, Liqun Liu, Sanhe Li, Yongzhi |
author_sort | Duan, Liqun |
collection | PubMed |
description | We present a rare case of a 69-year-old male patient with serendipitous urethral melanoma. He complained of dysuria and recurrent urinary retention and was initially diagnosed with benign prostatic hyperplasia. Accidentally, a dark-brown pigmented macula was found in the distal urethra at the end of transurethral prostatectomy when we exited the resectoscope, transurethral resection of the nidus and sent to pathological examination showed the characteristics of melanoma. No other lesions were found on further examination and the patient preferred a close follow-up cystoscopy rather than an immediate urethrectomy. Unsurprisingly, he relapsed in the urethra with the local disease three months later and we treated him with partial urethrectomy, followed by watchful waiting for 11 months. However, the patient was readmitted for hematuria, and (18)F-FDG PET-CT showed a large number of pelvic and bone metastatic lesions. Therefore, eight cycles of single-agent dacarbazine chemotherapy were administered, and the disease was demonstrated prolonged stabilization. Follow-up was conducted every 3 months, during which time palliative transurethral resection of the melanoma in the bladder was performed to control urinary tract infections. Although the prognosis of the disease is extremely poor, this patient has gained more than 50 months of overall survival and is alive to date. |
format | Online Article Text |
id | pubmed-8798279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87982792022-02-02 Primary malignant melanoma of the male urethra: a case report Duan, Liqun Liu, Sanhe Li, Yongzhi Transl Cancer Res Case Report We present a rare case of a 69-year-old male patient with serendipitous urethral melanoma. He complained of dysuria and recurrent urinary retention and was initially diagnosed with benign prostatic hyperplasia. Accidentally, a dark-brown pigmented macula was found in the distal urethra at the end of transurethral prostatectomy when we exited the resectoscope, transurethral resection of the nidus and sent to pathological examination showed the characteristics of melanoma. No other lesions were found on further examination and the patient preferred a close follow-up cystoscopy rather than an immediate urethrectomy. Unsurprisingly, he relapsed in the urethra with the local disease three months later and we treated him with partial urethrectomy, followed by watchful waiting for 11 months. However, the patient was readmitted for hematuria, and (18)F-FDG PET-CT showed a large number of pelvic and bone metastatic lesions. Therefore, eight cycles of single-agent dacarbazine chemotherapy were administered, and the disease was demonstrated prolonged stabilization. Follow-up was conducted every 3 months, during which time palliative transurethral resection of the melanoma in the bladder was performed to control urinary tract infections. Although the prognosis of the disease is extremely poor, this patient has gained more than 50 months of overall survival and is alive to date. AME Publishing Company 2021-11 /pmc/articles/PMC8798279/ /pubmed/35116351 http://dx.doi.org/10.21037/tcr-21-1150 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Case Report Duan, Liqun Liu, Sanhe Li, Yongzhi Primary malignant melanoma of the male urethra: a case report |
title | Primary malignant melanoma of the male urethra: a case report |
title_full | Primary malignant melanoma of the male urethra: a case report |
title_fullStr | Primary malignant melanoma of the male urethra: a case report |
title_full_unstemmed | Primary malignant melanoma of the male urethra: a case report |
title_short | Primary malignant melanoma of the male urethra: a case report |
title_sort | primary malignant melanoma of the male urethra: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798279/ https://www.ncbi.nlm.nih.gov/pubmed/35116351 http://dx.doi.org/10.21037/tcr-21-1150 |
work_keys_str_mv | AT duanliqun primarymalignantmelanomaofthemaleurethraacasereport AT liusanhe primarymalignantmelanomaofthemaleurethraacasereport AT liyongzhi primarymalignantmelanomaofthemaleurethraacasereport |